Dominik Leitz

Mr. Dominik Leitz

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DLDominik Leitz
Dominik Leitz
JDJulia Duerr
Julia Duerr
SMSurafel Mulugeta
Surafel Mulugeta
AAAyça Seyhan Agircan
Ayça Seyhan Agircan
Stefan ZimmermannStefan Zimmermann
Stefan Zimmermann
MMMarcus Mall
Marcus Mall
Recent studies found that expression of NEDD4-2 is reduced in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and that the conditional deletion of Nedd4-2 in lung epithelial cells causes IPF-like disease in adult mice via multiple defects, including dysregulation of the epithelial Na+ channel (ENaC), TGFβ signaling and the biosynthesis of surfactant protein-C proprotein (proSP-C). However, knowledge of the impact of congenital deletion of Nedd4-2 on the lung phenotype remains limited. In this study, we therefore determined the effects of congenital deletion of Nedd4-2 in the lung epithelial cells of neonatal doxycycline-induced triple transgenic Nedd4-2fl/fl/CCSP-rtTA2S-M2/LC1 mice, with a focus on clinical phenotype, survival, lung morphology, inflammation markers in BAL, mucin expression, ENaC function and proSP-C trafficking. We found that the congenital deletion of Nedd4-2 caused a rapidly progressive lung disease in neonatal mice that shares key features with interstitial lung diseases in children (chILD), including hypoxemia, growth failure, sterile pneumonitis, fibrotic lung remodeling and high mortality. The congenital deletion of Nedd4-2 in lung epithelial cells caused increased expression of Muc5b and mucus plugging of distal airways, increased ENaC activity and proSP-C mistrafficking. This model of congenital deletion of Nedd4-2 may support studies of the pathogenesis and preclinical development of therapies for chILD.

8 January 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
LDLorenzo D’aMico
Lorenzo D’aMico
ASAngelika Svetlove
Angelika Svetlove
ELElena Longo
Elena Longo
RMRuth Meyer
Ruth Meyer
BSBeatrice Senigagliesi
Beatrice Senigagliesi
CDChristian Dullin
Christian Dullin
Pulmonary fibrosis (PF) is a severe and progressive condition in which the lung becomes scarred over time resulting in pulmonary function impairment. Classical histopathology remains an important tool for micro-structural tissue assessment in the diagnosis of PF. A novel workflow based on spatial correlated propagation-based phase-contrast micro computed tomography (PBI-microCT), atomic force microscopy (AFM) and histopathology was developed and applied to two different preclinical mouse models of PF - the commonly used and well characterized Bleomycin-induced PF and a novel mouse model for progressive PF caused by conditional Nedd4-2 KO. The aim was to integrate structural and mechanical features from hallmarks of fibrotic lung tissue remodeling. PBI-microCT was used to assess structural alteration in whole fixed and paraffin embedded lungs, allowing for identification of fibrotic foci within the 3D context of the entire organ and facilitating targeted microtome sectioning of planes of interest for subsequent histopathology. Subsequently, these sections of interest were subjected to AFM to assess changes in the local tissue stiffness of previously identified structures of interest. 3D whole organ analysis showed clear morphological differences in 3D tissue porosity between transient and progressive PF and control lungs. By integrating the results obtained from targeted AFM analysis, it was possible to discriminate between the Bleomycin model and the novel conditional Nedd4-2 KO model using agglomerative cluster analysis. As our workflow for 3D spatial correlation of PBI, targeted histopathology and subsequent AFM is tailored around the standard procedure of formalin-fixed paraffin-embedded (FFPE) tissue specimens, it may be a powerful tool for the comprehensive tissue assessment beyond the scope of PF and preclinical research.

Verified
Journal Article
Open access
PDF file
TETheresa Antonia Engelmann
Theresa Antonia Engelmann
LKLars Knudsen
Lars Knudsen
DLDominik Leitz
Dominik Leitz
JDJulia Duerr
Julia Duerr
MBMichael F. Beers
Michael F. Beers
MOMatthias Ochs
Matthias Ochs
Our previous study showed that in adult mice, conditional Nedd4-2-deficiency in club and alveolar epithelial type II (AE2) cells results in impaired mucociliary clearance, accumulation of Muc5b and progressive, terminal pulmonary fibrosis within 16 weeks. In the present study, we investigated ultrastructural alterations of the alveolar epithelium in relation to interstitial remodeling in alveolar septa as a function of disease progression. Two, eight and twelve weeks after induction of Nedd4-2 knockout, lungs were fixed and subjected to design-based stereological investigation at the light and electron microscopic level. Quantitative data did not show any abnormalities until 8 weeks compared to controls. At 12 weeks, however, volume of septal wall tissue increased while volume of acinar airspace and alveolar surface area significantly decreased. Volume and surface area of alveolar epithelial type I cells were reduced, which could not be compensated by a corresponding increase of AE2 cells. The volume of collagen fibrils in septal walls increased and was linked with an increase in blood–gas barrier thickness. A high correlation between parameters reflecting interstitial remodeling and abnormal AE2 cell ultrastructure could be established. Taken together, abnormal regeneration of the alveolar epithelium is correlated with interstitial septal wall remodeling.

1 December 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
DLDominik Leitz
Dominik Leitz
PKPhilip Konietzke
Philip Konietzke
WWWilli L. Wagner
Willi L. Wagner
MMMara Mertiny
Mara Mertiny
CBClaudia Benke
Claudia Benke
MWMark O. Wielpuetz
Mark O. Wielpuetz
IPF diagnosis, particularly in early stages, remains challenging. In this study, micro-CT is used in conditional Nedd4-2−/− mice to closely monitor the onset and progression of progressive pulmonary fibrosis in vivo. Together with high-resolution post mortem micro-CT, this allowed us to track how nonspecific lung lesions develop into key IPF-like features. This approach offers a noninvasive method to monitor pulmonary fibrosis, providing a quantitative endpoint for the preclinical evaluation of novel antifibrotic strategies.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
DLDominik Leitz
Dominik Leitz
PKPhilip Konietzke
Philip Konietzke
WWWilli Wagner
Willi Wagner
JDJulia Duerr
Julia Duerr
HKHans-Ulrich Kauczor
Hans-Ulrich Kauczor
MWMark O. Wielpütz
Mark O. Wielpütz
Objective: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease which is usually diagnosed when irreversible lung damages already occurred. To date, little is known about the disease development before clinical manifestation. Recently, we developed a mouse model with conditional Nedd4-2 deficiency (Nedd4-2-/-) that produces a spontaneously progressive IPF-like disease which offers the opportunity for studies from the initiating event to terminal lung disease. Methods: We used in vivo and post mortem µCT imaging at different stages of IPF-like disease in conditional Nedd4-2-/- mice and applied a µCT based fibrosis score to quantify consolidations, honeycombing-like-lesions, fissural thickening, peripheral bronchiectasis, parenchymal lines, and reticulations. Further, we used in vivo longitudinal scans to study disease development in individual mice. Results: In vivo µCT imaging revealed the first fibrotic lesions 3 months after conditional Nedd4-2 deletion which further increasd in number and size the following months. In high resolution post mortem µCT scans, we found that unspecific interstitial alterations were detectable even at early stages of fibrotic lung disease, whereas IPF key features such as honeycombing-like-lesions develop late in disease progression. Conclusion: By µCT imaging, we were able to demonstrate the development of IPF key features in conditional Nedd4-2-/- mice and monitor disease progression of IPF like disease in vivo. Finally conditional Nedd4-2-/- mice are a valuable tool to investigate new diagnostic markers and evaluate new therapeutic strategies for IPF.

3 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DLDominik Leitz
Dominik Leitz
PKPhilip Konietzke
Philip Konietzke
WWWilli Wagner
Willi Wagner
MMMara Mertiny
Mara Mertiny
CBClaudia Benke
Claudia Benke
MWMark O. Wielpuetz
Mark O. Wielpuetz
Objectives: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease which is usually diagnosed late in advanced stages. Little is known about the subclinical development of IPF. We previously generated a mouse model with conditional Nedd4-2 deficiency ( Nedd4-2 −/− ) that develops IPF-like lung disease. The aim of this study was to characterize the onset and progression of IPF-like lung disease in conditional Nedd4-2 −/− mice by longitudinal micro- computed tomography (CT). Methods: In vivo micro-CT was performed longitudinally in control and conditional Nedd4- 2 −/− mice at 1, 2, 3, 4 and 5 months after doxycycline induction. Further, terminal in vivo micro-CT followed by pulmonary function testing and post mortem micro-CT was performed in age-matched mice. Micro-CT images were evaluated for pulmonary fibrosis using an adapted fibrosis scoring system. Results: Micro-CT is sensitive to detect onset and progression of pulmonary fibrosis in vivo and to quantify distinct radiological IPF-like features along disease development in conditional Nedd4-2 −/− mice. Nonspecific interstitial alterations were detected from 3 months, whereas key features such as honeycombing-like lesions were detected from 4 months onwards. Pulmonary function inversely correlated with in vivo (r=-0.725) and post mortem (r=-0.535) micro-CT fibrosis scores. Conclusion: Longitudinal micro-CT enables in vivo monitoring of onset and progression and detects radiologic key features of IPF-like lung disease in conditional Nedd4-2 −/− mice. Our data support micro-CT as sensitive quantitative endpoint for preclinical evaluation of novel antifibrotic strategies. NEW & NOTEWORTHY: IPF diagnosis, particularly in early stages, remains challenging. In this study micro-CT is used in conditional Nedd4-2 −/− mice to closely monitor the onset and progression of IPF-like lung disease. This allowed us to track for the first time how nonspecific lung lesions develop into key IPF-like features. This approach offers a non-invasive method to monitor pulmonary fibrosis in vivo , providing a quantitative endpoint for preclinical evaluation of novel antifibrotic strategies.